This study demonstrated that this interaction increases the dimerization and phosphorylation of EGFR, which enhances the activation of JAK2‐STAT3 signaling pathway, contributing to increasement of cisplatin resistance in NPC cells. The gene discussed is JAK2; the disease is nasopharyngeal carcinoma.